Oral administration of antibodies as prophylaxis and therapy in Campylobacter jejuni-infected chickens

Clinical and Experimental Immunology
K TsubokuraL Hammarström

Abstract

Passive immunity against gastrointestinal infections has recently been successfully applied as prophylaxis and therapy in patients in a variety of virally and bacterially induced infections. Campylobacter jejuni is frequently associated with acute diarrhoea in humans, and several species of animals have been shown to transmit the disease, although birds have been implicated as the main source of infection. We used bovine and chicken immunoglobulin preparations from the milk and eggs, respectively, of immunized animals for prophylactic and therapeutic treatment of chickens infected with C. jejuni. A marked prophylactic effect (a >99% decrease in the number of bacteria) was noted using either antibody preparation, whereas the therapeutic efficacy, i.e. when antibodies were given after the infection was established, was distinctly lower (80-95%) as judged by faecal bacterial counts. These observations may serve as a starting point for experiments aimed at elimination of the infection in an industrial or farm setting. It may also encourage future attempts to treat, prophylactically or therapeutically, patients with Campylobacter-induced diarrhoea.

Citations

Mar 10, 2001·The British Journal of Nutrition·H KorhonenH S Gill
May 26, 1999·Clinical and Experimental Immunology·C WeinerL Hammarström
Jan 20, 2010·Veterinary Immunology and Immunopathology·Wilmar Dias da Silva, Denise V Tambourgi
Apr 27, 2004·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·M GürtlerK Fehlhaber
May 18, 2016·Veterinary Immunology and Immunopathology·Chris J Hedegaard, Peter M H Heegaard
Oct 22, 2015·Nutrition Journal·Sandra MüllerChristopher Oelkrug
Feb 15, 2001·Journal of Pediatric Gastroenterology and Nutrition·S A SarkerL Hammarström
Sep 10, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ulrike DapuntJan Philippe Kretzer
Sep 13, 2012·Applied Biochemistry and Biotechnology·Xiaoyu LiLiji Jin
Oct 1, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Huaying ShiLidan Sun
May 22, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Lei DaiQijing Zhang
Jun 29, 2021·Frontiers in Immunology·Lucia LeeDaria Mochly-Rosen
Nov 17, 2021·Journal of Agricultural and Food Chemistry·Leheng ZhangSuqing Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Campylobacteriosis

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.